Abstract
Quantification of CK19 mRNA in peripheral blood (PB) and bone marrow (BM) from primary operable breast cancer (BC) patients pre- and postoperatively to investigate possible shedding of CK 19+ cells during the operation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have